AI aids study of bacteriophages to combat antibiotic-resistant infections

Tiny viruses that infect bacteria, known as bacteriophages, are emerging as a potential weapon against drug‑resistant infections. As antibiotic resistance escalates worldwide, researchers are turning to these natural predators of bacteria to develop alternative therapies. However, the complex mechanisms by which phages locate, attach to, and lyse their bacterial hosts remain incompletely understood, limiting their clinical deployment.

Artificial intelligence is now being applied to decode phage biology at scale. Machine‑learning models trained on genomic, structural, and infection‑outcome data can predict host range, identify functional genes, and simulate the dynamics of phage‑bacteria interactions. By accelerating the discovery of effective phage candidates and informing the design of engineered viruses, AI‑driven insights aim to bridge the gap between laboratory research and therapeutic use, offering a promising avenue to combat infections that no longer respond to conventional antibiotics.